英文字典中文字典Word104.com

中文字典辭典英文字典 a b c d e f g h i j k l m n o p q r s t u v w x y z

Rigel 音標拼音: [r'ɑɪdʒəl]

WordNet (r) 3.0 (2006) (WordNet)

Rigel
n 1: the brightest star in Orion [synonym: {Rigel}, {Beta Orionis}]

The Collaborative International Dictionary of English v.0.48 (gcide)

Rigel \Ri"gel\, n. [Ar. rijl, properly, foot.] (Astron.)
A fixed star of the first magnitude in the left foot of the
constellation Orion. [Written also {Regel}.]
[1913 Webster]

The Free On-line Dictionary of Computing (foldoc)

A {database} language? Based on {Pascal}. Listed by
M.P. Atkinson & J.W. Schmidt in a tutorial presented in
Zurich, 1989.

(1994-10-28)

請選擇你想看的字典辭典：

單詞	字典	翻譯
Rigel	查看　Rigel　在Google字典中的解釋	Google英翻中〔查看〕
Rigel	查看　Rigel　在Yahoo字典中的解釋	Yahoo英翻中〔查看〕

安裝中文字典英文字典查詢工具!

中文字典英文字典工具:

選擇顏色:

<style type="text/css">#word104_1 br {display:none;}</style>
<form id="word104_1" method="post" action="http://www.word104.com/index.php" target="_blank">
<div style="width: 140px;border:1px solid #000;background-color:#ffffff;padding: 0px 0px;margin: 0px 0px;align:center;text-align:center;overflow:hidden;"><div id="xcolor1_1" style="font-size:12px;color:#183a00;line-height:16px;font-family: arial; font-weight:bold;background:#94abf0;padding: 3px 1px;text-align:center;"><a href="http://www.word104.com/" alt="英文字典中文字典" title="英文字典中文字典" id="word_name104_1" style="color:#000000;font-size:14px;text-decoration:none;line-height:16px;font-family: arial;" >英文字典中文字典</a></div><table width=100% style='align:center;text-align:left;font-size:12px;background-color:#ffffff;color:#333333;'>
<tr><td style="text-align:center;border:0"><input type=hidden name="word104_hi" value="1">輸入中英文單字</td></tr><tr><td style="text-align:center;border:0"><input type="text" name="word104_input" value="" size=10 style="background-color:#ffffff;color:#000;text-decoration:none;font-family: arial;rial;border:1px solid #999;padding:1px!important;"></td></tr><tr style='line-height: 26px;'><td style="text-align:center;border:0"><input type=submit style="background-color:#ccc;color:#000;border:0 none;cursor:pointer;" value="查詢字典"></td></tr></table></div>
</form>

英文字典中文字典相關資料:

Rigel Pharmaceuticals, Inc. (RIGL)
Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel therapies that significantly improve the lives of patients with hematologic disorders and cancer
Rigel Announces Poster Presentations at the 2025 ASCO Annual Meeting . . .
Rigel's poster presentations will include data for GAVRETO ® (pralsetinib) for the treatment of metastatic rearranged during transfection (RET) fusion-positive non-small cell lung cancer (NSCLC), including final data from the Phase 1 2 ARROW study, and REZLIDHIA ® (olutasidenib) for the treatment of relapsed or refractory (R R) mutated
Rigel Provides Business Update and 2025 Outlook
Rigel Pharmaceuticals, Inc (Nasdaq: RIGL) is a biotechnology company dedicated to discovering, developing and providing novel therapies that significantly improve the lives of patients with hematologic disorders and cancer
Rigel Announces R289 Granted Fast Track Designation by the FDA for . . .
SOUTH SAN FRANCISCO, Calif , Dec 2, 2024 PRNewswire -- Rigel Pharmaceuticals, Inc (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and cancer, today announced that the…
Rigel Reports First Quarter 2025 Financial Results and Provides . . .
Rigel Pharmaceuticals, Inc (Nasdaq: RIGL) is a biotechnology company dedicated to discovering, developing and providing novel therapies that significantly improve the lives of patients with hematologic disorders and cancer
Pipeline :: Rigel Pharmaceuticals, Inc. (RIGL)
Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases
Rigel Announces R289 Granted Orphan Drug Designation by the FDA for MDS
SOUTH SAN FRANCISCO, Calif , Jan 9, 2025 PRNewswire -- Rigel Pharmaceuticals, Inc (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and cancer, today announced that the…
Rigel Reports Third Quarter 2024 Financial Results and Provides . . .
SOUTH SAN FRANCISCO, Calif , Nov 7, 2024 PRNewswire -- Rigel Pharmaceuticals, Inc (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and cancer, today reported financial results for the third quarter ended September 30, 2024, including sales of TAVALISSE ® (fostamatinib disodium hexahydrate) for the
Rigel Reports Fourth Quarter and Full Year 2024 Financial Results and . . .
Rigel Pharmaceuticals, Inc (Nasdaq: RIGL) is a biotechnology company dedicated to discovering, developing and providing novel therapies that significantly improve the lives of patients with hematologic disorders and cancer
Who We Are :: Rigel Pharmaceuticals, Inc. (RIGL)
Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases

中文字典-英文字典 2005-2009

|中文姓名英譯,姓名翻譯 |简体中文英文字典